US EditionThere's a Fierce Competition in the Weight Loss Drug Market, but Trump Can Have a Say in It Too
Summary by telex.hu
1 Articles
1 Articles
All
Left
1
Center
Right
It was recently revealed that the consumer drug from American Eli Lilly is more effective than the first-to-market drug from Novo Nordisk. The results could have a major business impact, but Donald Trump is considered an enemy in the eyes of both companies.
Coverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
